Purchase Order 36C25026P0252
Award Date 12/29/25
Potential Completion Date 12/28/26
Potential Value $146K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cleveland, OH 44106, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a firm fixed-price purchase order valued at $2.31M to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for ThyroSeq molecular diagnostic testing services. Under this contract, Cblpath will provide approximately 225 tests annually to multiple VA healthcare facilities within VISN 22, with interpretive reports to be delivered within 14 days of testing. The ThyroSeq test analyzes genetic mutations in thyroid...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6) awarded a $616,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on October 1, 2020, for ThyroSeq genomic classifier testing services supporting three VA Medical Centers located in Hampton, Richmond, and Salisbury. This contract requires no set-aside designation and will operate through September 30, 2025, with performance conducted from the vendor's facility in Port...
- This contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of ThyroSeq Genomic Classifier Tests. The $70,000.00 firm fixed price contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) on October 1, 2024, with a period of performance through September 30, 2025. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with extensive experience...
- This is a sole-source, firm-fixed-price contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10 to Cytopath Biopsy Lab Inc., operating as Cblpath, to provide the ThyroSeq v3 Genomic Classifier molecular diagnostic testing service. The $386,785.00 contract has a base year plus four one-year option years and supports thyroid cancer screening and diagnosis for the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana. Cblpath is a...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
- This federal contract award, valued at $16,415.00, is a Delivery Order placed under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA). The contract is for Cytopathology and ThyroSequence Testing Services to be provided by the prime contractor, Cytopath Biopsy Lab Inc., doing business as Cblpath. Cblpath is a for-profit organization that specializes in cancer screening and...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $8,000.00 firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, for thyroid molecular testing services. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with experience delivering ThyroSeq genetic testing to support cancer screening and diagnosis programs for the VA and Department of Defense. This contract is not set aside and is...
- This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for THRYOSEQUENCE TESTING services. The contract has a ceiling value of $248,145.69 and a period of performance through August 14, 2021. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (operating as Cblpath), a for-profit organization. The $28,000.00 contract is for cytopathology and ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of May 31, 2025...
- Cytopath Biopsy Lab Inc., operating as Cblpath, has been awarded a $84,000 firm fixed-price Blanket Purchase Agreement (BPA) call for ThyroSeq genomic classifier tests by Veterans Integrated Service Network 6, a regional component of the Department of Veterans Affairs. The award, effective October 1, 2024 with an ultimate completion date of September 30, 2025, represents a task order under the broader BPA vehicle established between Cblpath and VISN 6. The contract utilizes no set-aside...